Dr. Langer on Afatinib for Advanced Non-Small Cell Lung Cancer
0 Views
administrator
07/14/23
Corey Langer, MD, the director of Thoracic Oncology at the University of Pennsylvania, discuses afatinib, which was recently approved for first line EGFR-mutated advanced non-small cell lung cancer.
-
Category
Show more
Facebook Comments
No comments found